Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPlastic/Reconstructive SurgeryAetna stereolithographic 3D models Coverage | Open…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0613

    Stereolithographic Models and Implants

    Customize your policy alerts

    Sign up for Aetna Policy 0613 alerts

    Get alerted when Policy 0613 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Aetna's coverage stance for stereolithographic (3D printed) anatomic models, surgical guides, and implants primarily in plastic and reconstructive surgery; affects providers submitting claims to Aetna for these services.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerAetna
    PolicyStereolithographic Models and Implants
    Policy CodePolicy 0613
    Change TypeNo material change
    Effective DateMay 10, 2002
    Last ReviewSep 11, 2023
    Next Review DateJul 11, 2024
    Key ActionObtain prior authorization with documentation of medical necessity, defect size/location, imaging and QA validation when requesting custom 3‑D printed implants or experimental uses.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4experimental/investigational uses listed
    3listed T-codes for models/guides
    0prospective trials in plastic/recon
    350studies in systematic review
    510(k)FDA pathway cited

    Coverage Criteria for Stereolithographic Models, Guides, and Implants

    Experimental/Investigational

    Aetna considers the following experimental and investigational because their safety and effectiveness in improving outcomes has not been established:

    Experimental and Investigational Uses Listed: 1) Use of three dimensional (3D) stereolithographic models in plastic and reconstructive surgery; 2) Use of 3D stereolithographic models in penile surface mold brachytherapy; 3) Three-dimensional (3D) printed cranial implants; 4) Use of 3D printing of anatomic structures for pre-operative planning and other applications.

    These 4 specific uses are listed as experimental/investigational in the policy.

    Coverage when clinically indicated and documented

    Evidence supporting use of 3‑D printed implants and models is mixed; covered uses are typically when ALL of the following are met:

    Evidence-based coverage considerations: Patient-specific implant or model is supported by clinical need documented in the record (e.g., complex cranial defect where autologous bone is unsuitable), imaging and virtual planning were performed, and the device design is appropriate for the defect

    Based on clinical series and device clearances described

    Limited or experimental applications

    Situations where evidence is insufficient or uncertain:

    Insufficient evidence contexts: Use of 3-D printed devices for applications without rigorous or long-term assessments (majority of medical fields aside from oral/maxillofacial and musculoskeletal) or when benefits are only subjective and cost increases are not justified

    Systematic review found limited high-quality evidence outside certain specialties

    Evidence-based considerations and limitations

    Evidence summarized — applicability and limitations:

    Evidence summary: Patient-specific 3D-printed models have demonstrated feasibility and utility for pre-operative planning, device evaluation, simulation, training, and patient education across multiple specialties; quantitative accuracy varies by application and process control.

    See individual study metrics for deviations, QA methods, and limitations.

    QA and accuracy: Comprehensive QA (image acquisition, segmentation, printing, validation against phantom or CT of printed model) is necessary because measured deviations can range from sub-millimeter to several millimeters/degrees depending on technique and site.

    Examples: phantom differences ranged -0.32 to 0.13 mm; radial‑ulna mean distance -0.12 mm (range -0.57 to 0.34 mm); dental guide pooled angular ~3.08°; clinical implant deviations reported coronal/apical ~1.05 mm/1.63 mm and angular ~3.85°.

    Clinical outcome evidence: Small case series report clinical improvements (e.g., cranioplasty and lunate prosthesis series) but larger, well-designed studies are needed to validate clinical benefit and generalize findings.

    Authors consistently call for randomized or larger studies.

    Evidence summaries (not formal coverage criteria)

    Evidence summaries and applicability considerations from cited in‑vitro and cadaveric studies

    Dental implant guide accuracy findings: In-vitro and clinical studies of stereolithographic surgical guides report mean angular and positional deviations (pooled review: angular ~3.08°; entry ~1.14 mm; apex ~1.46 mm); a prospective clinical series reported mean coronal deviation 1.05 mm, apical 1.63 mm, and angular 3.85°. In a model experiment with 30 dentists, bucco‑lingual deviation at position #47 was larger (0.43 ± 0.19 mm) suggesting benefit of a bone-supported distal strut in distal extension situations.

    Authors note in-vitro model limitations (removed artificial gingiva, smoother surfaces) and call for randomized clinical trials.

    Cervical pedicle screw guide accuracy: Cadaveric study of patient-specific stereolithographic drill guide templates for atlanto-axial pedicle screw insertion demonstrated overall acceptable accuracy of 95% (100% for C1; 90% for C2).

    Authors recommend further investigation for C2 pedicle accuracy and testing in more representative specimens.

    Aetna excludes the specific applications listed below as experimental and investigational because their safety and effectiveness in improving clinical outcomes have not been established: (1) use of three-dimensional (3D) stereolithographic models in plastic and reconstructive surgery; (2) use of 3D stereolithographic models in penile surface mold brachytherapy; (3) three-dimensional (3D) printed cranial implants; and (4) use of 3D printing of anatomic structures for pre-operative planning and other applications. These four uses are designated investigational in this policy due to insufficient evidence demonstrating improved outcomes.

    Use of 3‑D printed devices for indications lacking rigorous comparative-effectiveness data and long-term outcome assessment may be considered investigational until higher-quality evidence is available. A systematic review found that most randomized controlled trials and higher-quality studies were concentrated in oral/maxillofacial and musculoskeletal fields, leaving efficacy and effectiveness undetermined for the majority of medical disciplines; consequently, applications outside well-studied areas should be treated cautiously.

    The policy and cited QA program do not provide specific, quantifiable standardized quality-assurance benchmarks for medical 3D printing. The authors note that their protocols were developed from experience with a single printer and a single segmentation software vendor and that broader, multi-institutional QA data are needed before universally applicable numeric QA standards can be adopted; therefore applicability may be limited when evidence derives from only one printer or one software workflow.

    Limitations of in‑vitro model studies are noted: investigators removed artificial gingiva and used master-model selection to reduce variability, which may not reproduce the effects of reflected soft tissue or the irregular bone contours encountered in live patients. These design features can affect seating and stability of stereolithographic guides and therefore limit the generalizability of in‑vitro findings to clinical practice.

    Stereolithographic modeling in plastic and reconstructive surgery is considered experimental and investigational because the literature is limited to case reports and feasibility discussions and there are no prospective studies demonstrating that stereolithographic models improve outcomes in these surgical procedures.

    The literature indicates that 3‑D printed parts increase procedural costs (printing and additional imaging) and, when a clinical advantage is unproven or undocumented, the additional expense may not be justified. In such situations, use of 3‑D printed components that raise costs without documented benefit may be considered not justified.

    Within the provided excerpts, the document does not specify any explicit conditions labeled as 'Not Medically Necessary'; the policy excerpts instead describe investigational designations, evidence limitations, and applicability concerns without listing distinct not-medically-necessary criteria.

    Coding and Regulatory Codes

    Codes mentioned in CPT/HCPCS section and related CPT codesmixed
    21076-21088Impression and custom preparation.
    21100Application of halo type appliance for maxillofacial fixation, includes removal (separate procedure).
    21110Application of interdental fixation device for conditions other than fracture or dislocation, includes removal.
    21120-21196Repair, revision, and/or reconstruction bones of face.
    21206Osteotomy, maxilla, segmental (e.g., Wassmund or Schuchard).
    21210Graft, bone; nasal, maxillary or malar areas (includes obtaining graft).
    21246Reconstruction of mandible or maxilla, subperiosteal implant; complete.
    30400-30465Rhinoplasty.
    42200-42225Palatoplasty.
    763763D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; not requiring image postprocessing on an independent workstation.
    1–10 of 21
    1/3
    Regulatory clearances mentionedmixed
    510(k)FDA 510(k) clearance pathway referenced for OsteoFab and OssDsign cranial PSI devices

    Provider Actions, Prior Authorization, and Documentation Requirements

    Prior Authorization

    Prior authorization may be required for anatomic model/guide T‑codes

    Use of the listed anatomic model (0559T/0560T) and anatomic guide (0561T/0562T) T-codes for indications that Aetna considers experimental/investigational may require prior authorization and are not covered for the experimental indications specified in this policy.

    • Affected CPT Category III codes: 0559T, 0560T, 0561T, 0562T
    • May require prior authorization when used for the experimental/investigational indications listed in the policy
    Prior Authorization

    Prior authorization for custom 3‑D printed implants

    Prior authorization may be required for custom 3‑D printed patient‑specific implants; submit documentation of medical necessity, defect size and location, and why alternatives (e.g., autologous bone grafting) are unsuitable.

    • Describe the clinical need and medical necessity for a custom implant
    • Specify defect dimensions and anatomical location

    Background and Policy Scope

    Stereolithography (SLA) is an additive manufacturing process that converts DICOM imaging data (CT or MRI) into 3‑D models by laser-directed photo-polymerization of a photosensitive resin, producing stacked slices that form a physical replica. SLA bio-models are used primarily to visualize facial bony structures, assist preoperative planning, allow rehearsal of osteotomies and grafting decisions, and help surgeons appreciate three-dimensional spatial displacements prior to reconstructive procedures.

    Definitions

    inv-32: Stereolithography (SLA) — definition and context
    DefinitionAn industrial rapid prototyping process using CAD data and a laser-directed photo-polymerization bath to produce 3‑D models as stacked slices of photosensitive resin.
    Primary imaging sourcesTypically created from CT or MRI imaging datasets for maxillofacial and other bony anatomy visualization.
    Clinical usesUsed to visualize facial skeleton, assist surgical planning, rehearsal, and measurement of deformities in plastic/reconstructive procedures.
    Evidence noteProspective clinical studies demonstrating improved outcomes in plastic and reconstructive surgery are lacking; considered experimental/investigational for these indications.
    inv-33: Anatomic model / Anatomic guide (T-codes)
    CPT Category III codes
    Policy Summary
    PayerAetna
    PolicyStereolithographic Models and Implants
    Policy CodePolicy 0613
    Change TypeNo material change
    Effective DateMay 10, 2002
    Last ReviewSep 11, 2023
    Next Review DateJul 11, 2024
    Key ActionObtain prior authorization with documentation of medical necessity, defect size/location, imaging and QA validation when requesting custom 3‑D printed implants or experimental uses.
    SourceLink
    On This Page
    Coverage Criteria for Stereolithographic Models, Guides, and ImplantsCoding and Regulatory CodesProvider Actions, Prior Authorization, and Documentation RequirementsBackground and Policy ScopeDefinitions
    Limitations and concerns: Printed materials and static models may not reproduce native tissue mechanical properties or dynamic physiology; process heterogeneity, costs, and lack of standardized QA limit generalizability.

    Example: TangoPlus stiffness differed from porcine mitral valve tissue; no standard 3D printing process across studies.

  1. Document that alternatives such as autologous bone graft are unsuitable or contraindicated
  2. Documentation Required

    Document pre‑procedure model creation and QA steps

    When models or guides are used, document imaging acquisition, all segmentation/processing steps, and QA validation of the printed model including quantitative measurement of deviations between the printed model and source data.

    • Imaging modality and parameters used (e.g., CT slice thickness)
    • Segmentation and file conversion workflow (DICOM → STL) and software used
    • QA validation method and results (e.g., CT scan of printed model registered to original images with point‑to‑point distance calculations)
    Note

    No specific prior authorization codes specified in excerpts

    The policy sections provided include policy history and review dates but do not specify required prior authorization codes or explicit administrative code‑level requirements in the excerpts.

    • Policy history and review dates are listed (last review 09/11/2023; effective 05/10/2002)
    • No specific prior authorization code requirements are specified in the provided excerpts
    Documentation Required

    Document rationale when choosing custom implant over autologous graft

    If a custom printed implant is chosen instead of autologous bone grafting, document the rationale—such as donor‑site morbidity, donor availability, or defect size—that makes autologous grafting unsuitable.

    • Comparison to autologous bone grafting and justification for selecting a custom implant
    • Any clinical considerations (e.g., donor‑site morbidity, unavailable donor bone, defect too large)
    Documentation Required

    Record planned vs achieved implant position metrics for dental guides

    For stereolithographic dental guides, document planned implant positions and capture outcome metrics comparing planned versus achieved implant position (lateral, depth, and angular deviations).

    • Planned coronal/apical position and angle from digital plan
    • Post‑operative measurements of lateral (coronal/apical), depth, and angular deviations using metrology or imaging software
    Documentation Required

    Document lack of prospective outcome evidence in plastic/reconstructive surgery

    Document the state of clinical evidence when submitting for coverage—note that prospective clinical studies demonstrating improved outcomes in plastic and reconstructive surgery are lacking and this investigational designation may not be overcome solely by anecdotal reports.

    • Reference that literature is limited to case reports and feasibility discussions
    • Acknowledge no prospective studies proving improved plastic/reconstructive surgery outcomes
    Documentation Required

    Provide device type, FDA status, and planning details

    Include device and planning documentation with submissions: state the device type, FDA clearance status when applicable (e.g., OsteoFab or OssDsign 510(k) clearances), and provide imaging and virtual planning data and operative reports describing fit and intraoperative findings.

    • Device description and material
    • FDA regulatory status or 510(k) clearance citations when applicable
    • Imaging and virtual planning files used to design the device and operative fit/assessment notes
    Documentation Required

    Perform and document model validation and QA measurements

    Validate printed models using both qualitative inspection and quantitative measurement—examples include scanning the printed model with high‑resolution CT and registering it to the original patient images to calculate point‑to‑point distances.

    • Qualitative fit and physical inspection records
    • Quantitative comparison (CT scan of printed model registered to source images; point‑by‑point distance calculations)
    • Phantom‑based end‑to‑end QA comparisons when available
    Documentation Required

    Include CT‑to‑STL methods and pre/post‑op measurement protocols

    Document imaging and measurement methods used to create STL files (e.g., CT imaging parameters) and any pre‑ and post‑operative measurement protocols used in studies (metrology software or image registration methods).

    • CT acquisition details and slice thickness used to generate STL files
    • Description of metrology or image‑registration software and measurement endpoints used for pre/post comparisons
    Denial Risk

    Denial risk: experimental/investigational services

    Services involving stereolithographic models, 3‑D printed cranial implants, or 3‑D printing for pre‑operative planning that are designated experimental/investigational by this policy are subject to denial.

    • Policy lists use in plastic/reconstructive surgery, penile mold brachytherapy, cranial implants, and pre‑operative planning as experimental/investigational
    • Such services may be denied coverage due to insufficient evidence of improved outcomes
    Denial Risk

    Denial risk if clinical advantage and cost‑effectiveness not documented

    Because 3‑D printing can increase costs (fabrication and additional imaging), failure to document a clear clinical advantage or cost‑effectiveness may lead to coverage denial.

    • Document any demonstrated reductions in OR time, complications, or other clinical benefits to justify added costs
    • Include cost comparisons to autologous or standard approaches when available
    Denial Risk

    Denial risk for QA deficiencies and potential model inaccuracies

    Lack of standardized QA across printers, imaging modalities, or segmentation software can produce unacceptable model inaccuracies; ensure QA procedures and validation data are submitted to mitigate this risk.

    • Describe institution‑level QA processes and any phantom‑based validation performed
    • Report limitations if QA relied on a single printer or single‑vendor software
    Note

    No explicit administrative/coding denial triggers in excerpts

    In the provided excerpts there are no explicit administrative or coding denial triggers (e.g., specific claim edits) described; however, therapeutic indications listed as investigational remain at risk for denial.

    • No explicit coding/administrative denial triggers are specified in the cited sections
    • Investigational indications themselves remain subject to coverage denial
    Note
    Step Therapy

    No step therapy requirements described

    No step therapy requirements are described in the provided policy excerpts.

    • Policy does not specify any prerequisite therapies or stepwise treatment requirements
    Documentation Required

    Supply device and planning documentation for authorization review

    Ensure device type, FDA clearance status (when applicable), imaging and virtual planning data, and operative reports are available to support prior authorization and medical‑necessity review.

    • List device brand/name and materials
    • Provide any FDA 510(k) documentation or clearance references
    • Attach imaging datasets and planning files used to design the implant or guide
    0559T: Anatomic model 3D‑printed from image data set(s); first individually prepared and processed component of an anatomic structure.
    Additional component code0560T: Each additional individually prepared and processed component of an anatomic structure (list separately).
    Anatomic guide codes0561T: Anatomic guide 3D‑printed and designed from image data set(s); first anatomic guide; 0562T: Each additional anatomic guide.
    Policy noteThese T‑codes are listed in the policy CPT/HCPCS section and may be subject to prior authorization when used for indications deemed experimental/investigational.
    inv-34: Stereolithography (SLA) / Rapid prototyping (RP)
    DefinitionAdditive manufacturing (rapid prototyping) techniques used to fabricate 3‑D scaffolds or models with controlled architecture to support tissue engineering and patient‑specific constructs.
    Example techniquesIncludes stereolithography (SLA), selective laser sintering, and fused deposition modeling as RP technologies applied to scaffold fabrication.
    Potential advantagesRP can improve mechanical strength, pore geometry, and reproducibility versus conventional scaffold fabrication methods.
    Development considerationsSelection of biomaterials, process parameters, and scaffold design are critical for efficacy and further development of RP‑based bone tissue engineering.
    inv-35: Patient-specific implant (PSI)
    DefinitionA custom implant designed from patient imaging and manufactured via additive manufacturing to fit a specific cranial defect (patient‑specific implant, PSI).
    Regulatory examplesFDA 510(k) clearances cited for OsteoFab Patient Specific Cranial Device (PEKK polymer) and OssDsign Cranial PSI (calcium‑phosphate ceramic with titanium skeleton).
    Indication specificsOssDsign Cranial PSI indicated for non‑load‑bearing cranial defect reconstruction in adults with completed cranial growth and intact dura (with or without duraplasty).
    Documentation requirementPrior authorization for custom 3‑D printed implants may require evidence of medical necessity, defect size/location, and why autologous bone is unsuitable.
    inv-36: Stereolithographic (SLA) model / stereolithographic surgical guide
    DefinitionA patient‑specific anatomic replica or surgical template produced by converting DICOM imaging into STL files that are fabricated by additive manufacturing (stereolithography) for planning, simulation, or guidance.
    Workflow stepsTypical process includes image acquisition, segmentation/processing, STL file generation, 3D printing, cleaning/finishing, and model validation.
    Validation methodsValidation described by scanning printed model with high‑resolution CT and registering to original patient images with point‑by‑point distance calculations.
    Clinical contextUsed for surgical planning, rehearsal, device evaluation, and patient education across specialties, though outcome evidence varies.
    inv-37: QA program for medical 3D printing
    Program definitionA systematic interdisciplinary QA program assessing accuracy and precision at each step: image acquisition, segmentation/processing, 3‑D printing, cleaning, and validation.
    Validation componentsIncludes phantom‑based end‑to‑end QA, physical fit tests, image‑based measurements, and point‑by‑point distance calculations between printed models and source data.
    Observed accuracyMeasured differences in QA testing ranged from -0.57 to 0.34 mm (mean distances reported in examples), highlighting process‑level variability.
    RecommendationEstablish interdisciplinary QA methodologies to contribute toward standardization of medical 3‑D printing practices.
    inv-38: sGIS (static guided implant surgery)
    DefinitionA static, pre‑fabricated stereolithographic surgical guide used to guide implant placement according to a digital plan (static guided implant surgery, sGIS).
    Accuracy factorsGuide support type (tooth‑, bone‑, or combination‑supported) affects accuracy; distal free‑end situations may reduce stability and accuracy without added support.
    Clinical measurementIn dental sGIS studies, mean angular and positional deviations have been reported (examples in evidence summaries); guide stability modifications may improve results.
    Practical noteWhen using sGIS, document planned vs achieved implant position metrics as part of outcome tracking.
    inv-39: patient-specific drill guide template
    DefinitionA drill guide constructed from a stereolithographic 3‑D model (STL file) of patient anatomy to assist precise screw or implant placement.
    Application exampleUsed to guide pedicle screw insertion in atlanto‑axial cervical spine specimens via patient‑specific drill guide templates derived from CT->STL models.
    Accuracy outcomeIn an in‑vitro cadaver study of 60 pedicles (C1+C2), total acceptable accuracy for pedicle screw insertion was 95% (100% for C1; 90% for C2).
    LimitationFurther investigation recommended for C2 pedicle accuracy and testing in more realistic surgical simulations.